Skip to main content

Day: July 16, 2025

Nilörn Interim Report Q2, 2025

Period April – JuneOrder intake decreased by 1 percent to MSEK 205 (208) Net sales in SEK decreased by 10 percent to MSEK 237 (262) Net sales adjusted for currency effects amounted to MSEK 259, representing an underlying organic decrease of 1 percent Operating profit amounted to MSEK 16.0 (25.6) Profit before tax amounted to MSEK 14.2 (24.8) Net profit for the period amounted to MSEK 10.8 (18.7) Earnings per share amounted to SEK 0.95 (1.64)Period January – JuneOrder intake increased by 7 percent to MSEK 471 (441) Net sales in SEK decreased by 2 percent to MSEK 496 (504) Net sales adjusted for currency effects amounted to MSEK 519, representing an underlying organic increase of 3 percent Operating profit amounted to MSEK 39.0 (48.1) Profit before tax amounted to MSEK 35.1 (46.0) Net profit for the period amounted to MSEK 26.6...

Continue reading

Q1 Trading Statement for the three months ended 30 June 2025

            Intermediate Capital Group plc 16 July 2025 Q1 Trading Statement for the three months ended 30 June 2025 HighlightsAUM of $123bn; fee-earning AUM of $82bn; AUM not yet earning fees of $19bn Fee-earning AUM up 4%1 in the quarter, up 11%1 year-on-year Fundraising in the quarter of $3.4bn, driven by Europe IX ($1.5bn / €1.3bn) and Infrastructure Europe II ($1.2bn / €1.0bn). Focus from LPs on liquidity and investment performance is continuing to drive manager selection Infrastructure Europe has shown strong momentum into its final close, with Fund II receiving substantially more client capital than the prior vintage: at 30 June 2025 Infrastructure Europe II had a Total Fund Size of €2.5bn (Fund I: €1.5bn), and we expect to close a further €0.6bn before the end of the current quarter, reaching the hard cap for the strategy Europe...

Continue reading

Stellantis Discontinues Hydrogen Fuel Cell Technology Development Program

Stellantis Discontinues Hydrogen Fuel Cell Technology Development ProgramAs the hydrogen market is showing no development prospect at mid-term, Stellantis has decided to discontinue its hydrogen fuel cell technology development program. Series production of hydrogen-powered Pro One vans in Hordain, France, and Gliwice, Poland, ends. Stellantis is discussing alternatives for Symbio with its partners.AMSTERDAM, July 16, 2025 – Stellantis today announced its decision to discontinue its hydrogen fuel cell technology development program. Due to limited availability of hydrogen refueling infrastructure, high capital requirements, and the need for stronger consumer purchasing incentives, the Company does not anticipate the adoption of hydrogen-powered light commercial vehicles before the end of the decade. As a result, Stellantis will no...

Continue reading

Caledonia Mining Corporation Plc: Blanket Mine Q2 2025 Production and Guidance

Increased production guidance at Blanket Mine for 2025 ST HELIER, Jersey, July 16, 2025 (GLOBE NEWSWIRE) — Caledonia Mining Corporation Plc (“Caledonia” or “the Company”) (NYSE AMERICAN, AIM and VFEX: CMCL) announces gold production from the Blanket Mine (“Blanket”) in Zimbabwe for the quarter ended June 30, 2025 (“Q2 2025”) and the half year ended June 30, 2025 (“H1 2025”). All production numbers are expressed on a 100 per cent basis and are based on final assays from the refiner. Production and Guidance SummaryQ2 2025 gold production was 21,070 ounces, setting a new record for a second quarter; 20,773 ounces were produced in the second quarter of 2024. H1 2025 gold production was 39,741 ounces, a 5.1 % increase on the 37,823 ounces produced in the first half of 2024. Caledonia increases Blanket’s production guidance to 75,500...

Continue reading

Richemont posts solid start to the year for its first quarter ended 30 June 2025

AD HOC ANNOUNCEMENT PURSUANT TO ART. 53 LR 16 JULY 2025 RICHEMONT POSTS SOLID START TO THE YEAR FOR ITS FIRST QUARTER ENDED 30 JUNE 2025   Highlights for the quarter ended 30 June 2025Group sales at € 5.4 billion, up by 6% at constant exchange rates and by 3% at actual exchange rates in a volatile macroeconomic and geopolitical context Continued strength at Jewellery Maisons, up by 11% at constant exchange rates; softer sequential rate of decline at Specialist Watchmakers, down by 7%; ‘Other’, including Fashion & Accessories Maisons, at -1% Double-digit growth in Europe, the Americas and Middle East & Africa; stable sales in Asia Pacific at constant exchange rates; Japan down on high comparatives in prior-year period Consistent growth across all distribution channels, led by Jewellery Maisons Robust net cash position at € 7.4 billion,...

Continue reading

Production Temporarily Suspended at DNO Kurdistan Fields Following Explosions

Oslo, 16 July 2025 – DNO ASA, the Norwegian oil and gas operator, reports that operations at its Tawke license in the Kurdistan region of Iraq have been temporarily suspended following three explosions early this morning, one involving a small storage tank at Tawke and the other involving surface processing equipment at Peshkabir. There have been no injuries. The damage assessment is underway and the Company expects to restart production once the assessment is completed. For further information, please contact:Media: media@dno.noInvestors: investor.relations@dno.no – DNO ASA is a leading Norwegian oil and gas operator active in the Middle East, the North Sea and West Africa. Founded in 1971 and listed on the Oslo Stock Exchange, the Company holds stakes in onshore and offshore licenses at various stages of exploration, development and...

Continue reading

Interim report for Q2

Guidance for pre-tax profit lifted by DKK 100 million supported by a solid insurance service result and improvement in the underlying business in Q2Guidance for the insurance service result is lifted by DKK 50 million to DKK 1.6-1.8 billion excluding H2 run-offs. Guidance for the investment result is lifted by DKK 50 million to DKK 250 million. The insurance service result was a profit of DKK 520 million in Q2 2025 (DKK 312 million), which is the highest result realised to date. The result was driven by highly satisfactory premium growth, an improved claims experience and favourable developments in the expense ratio. Insurance revenue grew at a highly satisfactory rate of 8% to DKK 2,950 million (DKK 2,725 million), driven in particular by strong premium growth of 11% in Personal Lines. The undiscounted underlying claims experience...

Continue reading

Borregaard ASA: EBITDA1 of NOK 522 million in the 2nd quarter

Borregaard’s operating revenues increased to NOK 2,045 million (NOK 1,949 million)2 in the 2nd quarter of 2025. EBITDA1 reached NOK 522 million (NOK 510 million). The result in BioSolutions and BioMaterials increased while Fine Chemicals had a lower result. Continued growth in sales to agriculture was the main reason for the improved result in BioSolutions. In BioMaterials, the result increased due to higher sales prices, improved product mix and increased sales volume, partly offset by higher wood costs. Lower sales prices for bioethanol were the main reason for the weaker result in Fine Chemicals. The net currency effects were positive in all areas. Profit before tax was NOK 326 million (NOK 322 million). Earnings per share were NOK 2.56 (NOK 2.45). We are pleased to report improved results for both BioSolutions and BioMaterials, driven...

Continue reading

Banco Itaú Chile Schedules Second Quarter 2025 Financial Results Conference Call

SANTIAGO, Chile, July 15, 2025 (GLOBE NEWSWIRE) — BANCO ITAÚ CHILE (SSE: ITAUCL) announced today that it will release its results for the second quarter ended June 30, 2025, before the market opens in Santiago, on July 31, 2025. On Monday, August 11, 2025, at 9:00 A.M. Santiago time (9:00 A.M. ET), the Company’s management team will host a conference call to discuss the financial results. The call will be hosted by André Gailey, CEO; Emiliano Muratore, CFO; and Andrés Perez, Chief Economist. The quiet period starts on July 16. Webinar Details: Online registration:  https://mzgroup.zoom.us/webinar/register/WN_Zwa7qMydTu-u6c93fjgaMw All participants must pre-register using this link to join the webinar. Upon registering, each participant will be provided with details to connect to the call. Q&A session: The Q&A session...

Continue reading

Jin Medical Launches Production at Plant No. 3, Accelerating Global Delivery from the Chuzhou Manufacturing Facility

Beijing, China, July 15, 2025 (GLOBE NEWSWIRE) — Jin Medical International Ltd. (Nasdaq: ZJYL) (“Jin Medical”, and together with all its subsidiaries, the “Company”), a Nasdaq-listed provider of rehabilitation medical equipment, announced today that its wholly owned subsidiary, ZhongJin Medical Equipment (Anhui) Co., Ltd. (“Zhongjin Anhui”), has officially launched production at Plant No. 3 of Zhongjin Anhui’s intelligent manufacturing facility in Chuzhou, Anhui, China. With 19 years of expertise in rehabilitation technology, the Company is committed to accelerate the integration of the global rehabilitation device supply chain through its robust production and precision manufacturing capabilities. At Zhongjin Anhui’s intelligent manufacturing facility in Chuzhou, robotic arms operate with precision in temperature-controlled workshops,...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.